Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Rhythmic Auditory Stimulation and Dual-task Gait Training in Chronic Stroke

11. juli 2026 oppdatert av: Seda Karaca, Recep Tayyip Erdogan University

Combined Rhythmic Auditory Stimulation and Dual-task Gait Training in Individuals With Chronic Stroke: a Pre-post Study With Exploratory Age-stratified Analyses

Rhythmic auditory stimulation and dual-task gait training may improve post-stroke mobility, but evidence regarding integrated programmes and age-related differences in treatment response remains limited. The aim of the study is to evaluate changes in mobility, balance, motor dual-task performance, concern about falling, and health-related quality of life after a six-week combined programme, and to explore whether responses differed across age strata.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

This prospective single-group pre-post study included individuals with chronic stroke. Participants completed supervised rhythmic auditory stimulation and progressively intensified motor dual-task gait training three times weekly for six weeks. Outcomes included motor dual-task performance, Timed Up and Go, bilateral single-leg stance, Mini-BESTest, Falls Efficacy Scale-International, and SF-36. An independent assessor, unaware of previous scores and age-stratum allocation, conducted baseline and post-intervention assessments. Prespecified exploratory analyses compared changes across age strata.

Studietype

Intervensjonell

Registrering (Faktiske)

46

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • age ≥45 years
  • stroke ≥6 months previously
  • ability to walk at least 10 m independently or with minimal assistance
  • sufficient hearing to follow rhythmic auditory cues

Exclusion Criteria:

  • advanced aphasia
  • severe neglect, cognitive impairment,
  • marked visual impairment,
  • severe spasticity (Modified Ashworth Scale score15 ≥3)
  • severe cardiopulmonary disease
  • vestibular dysfunction
  • an orthopaedic condition limiting walking
  • progressive neurological disease

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Stroke Group
Participants completed a supervised six-week programme comprising three 30-minute sessions per week (18 sessions; planned dose, 540 minutes). During each session, they synchronized their steps with a metronome while performing tandem walking with progressively demanding object-carrying tasks. Participants maintained their usual walking speed and were instructed to give equal attention to gait and the concurrent motor task. Progression was designed by the research team in accordance with general motor-learning principles and involved predefined weekly increases in metronome tempo and concurrent motor-task complexity.
Annen: Rhythmic Auditory Stimulation and Motor Dual-Task Gait Training Programme
The intervention combined RAS with progressively intensified motor dual-task gait training.6 Participants completed a supervised six-week programme comprising three 30-minute sessions per week (18 sessions; planned dose, 540 minutes). During each session, they synchronized their steps with a metronome while performing tandem walking with progressively demanding object-carrying tasks. Participants maintained their usual walking speed and were instructed to give equal attention to gait and the concurrent motor task. Progression was designed by the research team in accordance with general motor-learning principles and involved predefined weekly increases in metronome tempo and concurrent motor-task complexity. provided that the preceding stage had been completed safely. All sessions were delivered individually by the same licensed physiotherapist experienced in neurology.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Motor dual-task performance
Tidsramme: at baseline and after the six-week programme
Participants completed a 10-m walk at their comfortable speed under single-task and motor dual-task conditions. In the dual-task condition, they carried a ball while walking and were instructed to give equal attention to both tasks. Three trials were performed under each condition, and mean completion time was used in the analysis. Positive values indicated greater dual-task interference.
at baseline and after the six-week programme
Functional mobility
Tidsramme: at baseline and after the six-week programme
Functional mobility was assessed using the Timed Up and Go test, with shorter completion times indicating better performance. One familiarization trial preceded the timed assessment.
at baseline and after the six-week programme
Balance
Tidsramme: at baseline and after the six-week programme
Dynamic balance was assessed using the 14-item Mini-BESTest, which evaluates anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait. Total scores range from 0 to 28, with higher scores indicating better balance. Static balance was assessed bilaterally using the Single-Leg Stance Test. Two trials were performed on each side, and the longest duration before foot contact, stance-foot movement, or loss of balance was recorded.
at baseline and after the six-week programme

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Recep Tayyip Erdogan University

Samarbeidspartnere

İstanbul Yeni Yüzyıl Üniversitesi

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

15. januar 2026

Primær fullføring (Faktiske)

15. mai 2026

Studiet fullført (Faktiske)

15. mai 2026

Datoer for studieregistrering

Først innsendt

11. juli 2026

Først innsendt som oppfylte QC-kriteriene

11. juli 2026

Først lagt ut (Faktiske)

16. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

11. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 2026/01-1781

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

I do not prefer.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere